Sonata Transcervical Fibroid Ablation System 2.2
Gynesonics, Inc. · K250705
FDA-authorized Predetermined Change Control Plan
- Company
- Gynesonics, Inc.
- 510(k)/De Novo #
- K250705
- Decision date
- 2025-04-02
- Panel
- Obstetrics/Gynecology
- Pathway
- 510(k)
- Category
- Non-AI
- PCCP type
- Unknown
- Monitoring commitment
- Unknown
Other Obstetrics/Gynecology PCCPs
Want the monitoring teardown?
We read the PCCP for Sonata Transcervical Fibroid Ablation System 2.2, then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.
Book a callSource: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.
This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.